In the Voelcker lab, we aim to gain a deeper understanding of the interactions between nanostructured materials and human cells and tissues, and their biomolecular products. To that effect, we are developing nanostructured materials and surface chemistries, with a focus on electrochemically etched meso- and macroporous materials. These systems are then optimised for applications in biosensing, drug delivery, regenerative medicine, microfluidics, and others.
Feel free to contact us regarding open positions, collaboration, and beyond.
Latest Papers
- Electrochemical biosensors: The beacon for food safety and qualityby Somayeh Hosseinikebria on February 16, 2025 at 11:00 am
Electrochemical biosensors transduce chemical reactions into measurable electrical signals by incorporating recognition components. Although they are capable of detecting a broad range of target […]
- Block copolymer-assembled nanopore arrays enable ultrasensitive label-free DNA detectionby Maximiliano Jesus Jara Fornerod on February 5, 2025 at 11:00 am
DNA detection via nanoporous-based electrochemical biosensors is a promising method for rapid pathogen identification and disease diagnosis. These sensors detect electrical current variations caused […]
- Mitochondrial segmentation and function prediction in live-cell images with deep learningby Yang Ding on January 17, 2025 at 11:00 am
Mitochondrial morphology and function are intrinsically linked, indicating the opportunity to predict functions by analyzing morphological features in live-cell imaging. Herein, we introduce MoDL, a […]
- Tailoring Design of Microneedles for Drug Delivery and Biosensingby Yuexi Lin on January 15, 2025 at 11:00 am
Microneedles (MNs) are emerging as versatile tools for both therapeutic drug delivery and diagnostic monitoring. Unlike hypodermic needles, MNs achieve these applications with minimal or no pain and […]
- Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitusby Chan Yew Low on January 15, 2025 at 11:00 am
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, leading to elevated blood sugar levels. Exogenous insulin can counteract the diminished response to […]
